Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) Return on invested capital
Veeva Systems Inc.'s return on invested capital over the twelve months to 31 July 2026 was 343.1%, up 255.5 percentage points from fiscal 2026 (87.6%). Over the past ten years it has ranged from 30.9% (fiscal 2016) to 488.0% (fiscal 2015); the current reading is higher than 83% of that period. That is above the Health Information Services industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | 87.6% | 24.23 |
| FY2025 | 63.4% | 19.86 |
| FY2024 | 43.5% | (3.27) |
| FY2023 | 46.8% | (12.23) |
| FY2022 | 59.0% | 19.81 |
| FY2021 | 39.2% | 8.28 |
| FY2020 | 30.9% | (63.48) |
| FY2019 | 94.4% | 25.97 |
| FY2018 | 68.4% | 12.03 |
| FY2017 | 56.4% | 25.50 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| VEEV Veeva Systems Inc. | 343.1% |
| DOCS Doximity, Inc. compare | 53.1% |
| HQY HealthEquity, Inc. compare | 8.24% |
| BTSG BrightSpring Health Services, Inc. compare | 7.56% |
| WAY Waystar Holding Corp. compare | 3.30% |
| HNGE Hinge Health Inc. compare | 0.00% |
| TEM Tempus AI, Inc. compare | −17.9% |
| TXG 10x Genomics compare | −20.2% |
| HTFL Heartflow, Inc. compare | −42.8% |
| Health Information Services industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement